After preparing the project-technical documentation, the FormaPharm group signed a contract with the investor FHI ZDRAVLJE AD Actavis Company from Leskovac. The Zdravlje Actavis factory from Leskovac is one of the most important drug manufacturers in Serbia and is owned by the mentioned investor, the company Actavis, a member of the Teva group, the largest pharmaceutical company in the world engaged in the production of generic pharmaceutical products.

The works refer to the improvement of the system for regulation of relative humidity of the storage facility, by introducing a new facility management system (BMS), which will control the existing system of heating, ventilation and air conditioning of the storage facility.

The performed works must be in accordance with the conditions prescribed by EU standards cGMP, EHS, TEVA, as well as with the conditions prescribed by the legislation of the Republic of Serbia, and the expertise and experience that our company has certainly allow us to meet the conditions in the best way.